Regulation of intestinal homeostasis and epithelial barrier by LPA

LPA 对肠道稳态和上皮屏障的调节

• 批准号: 9337341
• 负责人: Changhyon Chris Yun
• 金额: --
• 依托单位: VETERANS HEALTH ADMINISTRATION
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9337341
• 关键词: Acute; Affect; Atherosclerosis; Attenuated; Bacterial Translocation; Cells; Chemicals; Chronic; Colitis; Colon; Colon Carcinoma; Colorectal Cancer; Communities; Crohn' s disease; Disease; Electrolytes; Environment; Enzymes; Epithelial; Epithelial Cell Proliferation; Epithelial Cells; Epithelium; Etiology; Experimental Models; Family; Future; G-Protein-Coupled Receptors; Genetic; Goals; Growth Factor; Health; Homeostasis; Hospitalization; Hydrolysis; Ileitis; Immune; Immune response; Immune system; Immunity; Individual; Inflammation; Inflammatory; Inflammatory Bowel Diseases; Inflammatory disease of the intestine; Injury; Intestinal Mucosa; Intestines; Invaded; Leukocytes; Lysophosphatidic Acid Receptors; Lysophospholipase; Lysophospholipids; Macronutrients Nutrition; Maintenance; Malignant Neoplasms; Malnutrition; Mediating; Military Personnel; Minerals; Modality; Modeling; Molecular; Morbidity - disease rate; Mus; Nutrient; Pathogenicity; Patients; Permeability; Play; Predisposition; Process; Production; Proliferating; Recovery; Regulation; Resistance; Risk; Risk Factors; Role; Signal Transduction; Small Intestines; Sodium Dextran Sulfate; Therapeutic; Ulcerative Colitis; United States; Veterans; Villus; Work; Wound Healing; absorption; cancer cell; cell motility; cell type; cytokine; extracellular; gastrointestinal; improved; in vivo; injury and repair; intestinal crypt; intestinal homeostasis; lipid mediator; lysophosphatidic acid; microorganism; migration; novel; nutrient absorption; pathogen; public health relevance; repaired; restoration; solute; vzg-1 Receptor

DESCRIPTION (provided by applicant): PROJECT SUMMARY Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, affect more than 1 million people in the United States. IBD is a frequent cause of hospitalization among US military veterans. IBD increases the risk factor for other diseases such as colorectal cancer and atherosclerosis. Polarized epithelia in the intestine play an important role in inflammation by serving as a barrier between an invading pathogen and the immune system of the host. Damage to the epithelia compromises absorption of nutrients and mineral, often leading to malnutrition in patients with IBD. Hence, the ability to maintain the epithelial barrier integrity is critical in protecting the host from a hostile environment in the intestinal lumen. Intestinal epithelial proliferation and migration are requirements in wound healing, a process disrupted in IBD. Lysophosphatidic acid (LPA) is a lipid mediator with diverse growth factor-like effects. Extracellular LPA is produced by hydrolysis of circulating lysophospholipid by a lysophospholipase D known as autotaxin (ATX). The effects of LPA are mediated through a family of G protein- coupled receptors: LPA1R-LPA5R. LPA1R is the most abundant LPA receptor in the small intestine and colon, and yet the functional significance of LPA1R is poorly understood. The impetus of this application came from our recent findings that loss of LPA1R in the intestine results increased susceptibility to dextran sulfate sodium (DSS)- induced colitis by delaying the recovery process. We aim to further define the importance of LPA1R in chronic inflammation and determine how LPA1R regulates intestinal epithelial homeostasis (Aim 1). LPA is often regarded as a pro-inflammatory agent. We found that the expression level of LPA-producing ATX was increased in DSS- mediated colitis, and mice deficient in ATX expression showed resistance to DSS-induced colitis. However, deletion of ATX or chemical inhibition of ATX significantly delayed recovery from DSS-induced injury. Hence, LPA appear to have opposing effects during the onset of inflammation and recovery. We propose to investigate whether ATX is a potential target in treatment of intestinal inflammation. We will use genetic deletion and chemical inhibition of ATX to assess the effects on acute and chronic inflammation (Aim 2). Individuals with IBD and, particularly, those with Crohn's disease are at risk for a variety of nutritional deficiencies because of decreased nutrient absorption and/or increased losses of macronutrients. Deletion or inhibition of LPA1R decreased expression of several transporters of nutrients and electrolytes. On the contrary, treating mice with spontaneous ileitis with LPA increased transporter expression, suggesting a beneficial role of LPA on the intestinal absorptive function. We propose evaluate whether LPA could be used to enhance epithelial absorptive functions associated with IBD (Aim 3). The overarching goal of this application is to investigate the importance of LPA in maintenance of intestinal epithelial homeostasis and regulation of the epithelial barrier and absorptive functions. Successful completion of the proposed work should provide a better understanding of the LPA1R- mediated effects, which together with the proposed study on the major LPA-producing ATX, will benefit maintenance of healthy intestine and provide potential therapeutic modality for treatment of inflammatory diseases.

描述（由申请人提供）： 炎症性肠病（IBD），包括克罗恩病和溃疡性结肠炎，在美国影响超过100万人。IBD是一种常见原因 美国退伍军人的住院率。IBD增加了其他疾病的风险因素，如结肠直肠癌和动脉粥样硬化。肠中的极化上皮细胞通过充当入侵病原体和宿主免疫系统之间的屏障而在炎症中起重要作用。上皮细胞的损伤损害了营养物质和矿物质的吸收，通常导致IBD患者营养不良。因此，维持上皮屏障完整性的能力对于保护宿主免受肠腔中的不利环境的影响至关重要。肠上皮细胞增殖和迁移是创伤愈合的需要，创伤愈合是IBD中中断的过程。溶血磷脂酸（LPA）是一种具有多种生长因子样作用的脂质介质。细胞外LPA是由称为自分泌运动因子（ATX）的溶血磷脂酶D水解循环溶血磷脂产生的。LPA的作用是通过G蛋白偶联受体家族介导的：LPA 1 R-LPA 5 R。LPA 1 R是小肠和结肠中最丰富的LPA受体，但LPA 1 R的功能意义知之甚少。这项应用的动力来自于我们最近的发现，即肠道中LPA 1 R的丢失通过延迟恢复过程增加了对葡聚糖硫酸钠（DSS）诱导的结肠炎的易感性。我们的目的是进一步确定LPA 1 R在慢性炎症中的重要性，并确定LPA 1 R如何调节肠上皮细胞的稳态（目的1）。LPA通常被认为是促炎剂。我们发现，在DSS介导的结肠炎中，产生LPA的ATX的表达水平增加，并且ATX表达缺陷的小鼠显示出对DSS诱导的结肠炎的抗性。然而，删除ATX或化学抑制ATX显着延迟恢复DSS诱导的损伤。因此，LPA似乎在炎症发作和恢复期间具有相反的作用。我们建议研究ATX是否是治疗肠道炎症的潜在靶点。我们将使用ATX的遗传缺失和化学抑制来评估对急性和慢性炎症的影响（目的2）。患有IBD的个体，特别是患有克罗恩病的个体，由于营养吸收减少和/或大量营养素损失增加而处于各种营养缺乏的风险中。LPA 1 R的缺失或抑制降低了几种营养素和电解质转运蛋白的表达。相反，用LPA治疗患有自发性回肠炎的小鼠增加了转运蛋白的表达，表明LPA对肠吸收功能的有益作用。我们建议评估LPA是否可用于增强与IBD相关的上皮吸收功能（目的3）。本申请的首要目标是研究LPA在维持肠上皮稳态和调节上皮屏障和吸收功能中的重要性。拟议工作的成功完成将使我们更好地了解LPA 1 R介导的作用，这与拟议的主要LPA产生ATX的研究一起，将有利于维持健康的肠道，并为治疗炎症性疾病提供潜在的治疗方式。